BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 21493001)

  • 1. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.
    Cesarman E
    Cancer Lett; 2011 Jun; 305(2):163-74. PubMed ID: 21493001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.
    Du MQ; Bacon CM; Isaacson PG
    J Clin Pathol; 2007 Dec; 60(12):1350-7. PubMed ID: 18042691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gammaherpesviruses and lymphoproliferative disorders.
    Cesarman E
    Annu Rev Pathol; 2014; 9():349-72. PubMed ID: 24111911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.
    Du MQ; Liu H; Diss TC; Ye H; Hamoudi RA; Dupin N; Meignin V; Oksenhendler E; Boshoff C; Isaacson PG
    Blood; 2001 Apr; 97(7):2130-6. PubMed ID: 11264181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection of HHV-6 and HHV-8 is rare in primary effusion lymphoma.
    Asou H; Tasaka T; Said JW; Daibata M; Kamada N; Koeffler HP
    Leuk Res; 2000 Jan; 24(1):59-61. PubMed ID: 10634647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.
    Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M
    J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Oncogenic
    Atamna A; Yahav D; Hirzel C
    Transpl Int; 2023; 36():11856. PubMed ID: 38046068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.
    Dolcetti R; Di Luca D; Carbone A; Mirandola P; De Vita S; Vaccher E; Sighinolfi L; Gloghini A; Tirelli U; Cassai E; Boiocchi M
    J Med Virol; 1996 Apr; 48(4):344-53. PubMed ID: 8699167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germinotropic lymphoproliferative disorder: a systematic review.
    Zanelli M; Zizzo M; Bisagni A; Froio E; De Marco L; Valli R; Filosa A; Luminari S; Martino G; Massaro F; Fratoni S; Ascani S
    Ann Hematol; 2020 Oct; 99(10):2243-2253. PubMed ID: 32307569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus type-8 (HHV-8) in haematopoietic neoplasia.
    Gaidano G; Pastore C; Gloghini A; Volpe G; Capello D; Polito P; Vaccher E; Tirelli U; Saglio G; Carbone A
    Leuk Lymphoma; 1997 Jan; 24(3-4):257-66. PubMed ID: 9156655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology Frontiers in γ-Herpesviruses Treatments.
    Granato M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
    J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of gammaherpesvirus-related neoplastic disorders in the immunosuppressed host.
    Little RF; Yarchoan R
    Semin Hematol; 2003 Apr; 40(2):163-71. PubMed ID: 12704593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology of AIDS-related Kaposi's sarcoma and lymphoma.
    Boshoff C; Whitby D; Talbot S; Weiss RA
    Oral Dis; 1997 May; 3 Suppl 1():S129-32. PubMed ID: 9456674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus reactivation influences clonal evolution in human herpesvirus-8-related lymphoproliferative disorders.
    Granai M; Facchetti M; Mancini V; Goedhals J; Sherriff A; Mundo L; Bellan C; Amato T; Sorrentino E; Ungari M; Raphael M; Leoncini L; Facchetti F; Lazzi S
    Histopathology; 2021 Dec; 79(6):1099-1107. PubMed ID: 34431125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancers associated with human gammaherpesviruses.
    Wen KW; Wang L; Menke JR; Damania B
    FEBS J; 2022 Dec; 289(24):7631-7669. PubMed ID: 34536980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral participation in cellular and microenvironmental transformation and amplification towards malignancy in AIDS patients.
    Agius LM
    Med Hypotheses; 2004; 62(4):593-9. PubMed ID: 15050113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome.
    Katz BZ; Berkman AB; Shapiro ED
    J Pediatr; 1992 Feb; 120(2 Pt 1):228-32. PubMed ID: 1310507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.